FDA.reportPublic FDA data

Application 207378

Type
ANDA
Sponsor
INVAGEN PHARMS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001FENOFIBRATE (MICRONIZED)FENOFIBRATECAPSULE;ORAL67MGNoNo
002FENOFIBRATE (MICRONIZED)FENOFIBRATECAPSULE;ORAL134MGNoNo
003FENOFIBRATE (MICRONIZED)FENOFIBRATECAPSULE;ORAL200MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
16714-739FenofibratefenofibrateNorthstar Rx LLCANDACurrent
16714-739FenofibratefenofibrateNorthstar Rx LLCANDACurrent
16714-739FenofibratefenofibrateNorthstar Rx LLCANDACurrent
16714-740FenofibratefenofibrateNorthstar Rx LLCANDACurrent
16714-740FenofibratefenofibrateNorthstar Rx LLCANDACurrent
16714-740FenofibratefenofibrateNorthstar Rx LLCANDACurrent
16714-741FenofibratefenofibrateNorthstar Rx LLCANDACurrent
16714-741FenofibratefenofibrateNorthstar Rx LLCANDACurrent
16714-741FenofibratefenofibrateNorthstar Rx LLCANDACurrent
50090-4698FenofibratefenofibrateA-S Medication SolutionsANDACurrent
50090-4698FenofibratefenofibrateA-S Medication SolutionsANDACurrent
68071-4088FenofibratefenofibrateNuCare Pharmaceuticals,Inc.ANDACurrent
69097-894FenofibratefenofibrateCipla USA Inc.,ANDACurrent
69097-894FenofibratefenofibrateCipla USA Inc.,ANDACurrent
69097-894FenofibratefenofibrateCipla USA Inc.,ANDACurrent
69097-895FenofibratefenofibrateCipla USA Inc.,ANDACurrent
69097-895FenofibratefenofibrateCipla USA Inc.,ANDACurrent
69097-895FenofibratefenofibrateCipla USA Inc.,ANDACurrent
69097-896FenofibratefenofibrateCipla USA Inc.,ANDACurrent
69097-896FenofibratefenofibrateCipla USA Inc.,ANDACurrent
69097-896FenofibratefenofibrateCipla USA Inc.,ANDACurrent